Great product any shareholders, page-6

This company needs some decent exposure, and a good run of sales momentum.

I agree that the product works (from my own experience), and whilst expensive it should be able to hold its own in the premium price range.

It has been frustrating see sales momentum build and then dissipate. Given where other listed probiotics companies are trading, even the slightest hint of sustained cash flow surpluses and continued momentum of revenue will see it through the roof.

But it needs more exposure. Would like to see the new management team undertake a few roadshows.